ERBB2 and breast carcinoma: The amplification of HER2 in breast cancer leads to severe alterations in growth and proliferation signaling, e.g., mitogen-activated protein kinase (MAPK) signaling, resulting in a more aggressive and invasive growth of the tumor1,2.